Fastcure 10 mg 21 Capsules

-Gastroesophageal reflux disease: Initial therapy: Mild/intermittent disease (<2 episodes/week) and no evidence of erosive esophagitis: Oral: 10 mg once daily; can increase to 20 mg once daily after 4 to 8 weeks if necessary. Discontinue once asymptomatic for 8 weeks, Severe and/or frequent symptoms (≥2 episodes/week) and/or erosive esophagitis: Oral: 20 to 40 mg once daily; once symptoms are controlled, continue for at least 8 weeks. -Helicobacter pylori eradication: Oral: 20 mg or 40 mg twice daily as part of an appropriate combination regimen with antibiotics. -Primary prevention of nonsteroidal anti-inflammatory drug (including aspirin)–induced ulcers: Oral: 20 mg once daily for the duration of high-risk NSAID use. -Treatment and secondary prevention of Peptic ulcer disease: Uncomplicated ulcer: Oral: 20 to 40 mg once daily. Duration depends on the size, location, and cause of the ulcer and ranges from 4 to 8 weeks. In patients with refractory or recurrent disease, may increase the dose to 20 to 40 mg twice daily. Complicated ulcer (perforation, penetration, or gastric outlet obstruction): Oral: 40 mg twice daily for 4 weeks, followed by 40 mg once daily. Duration depends on the location and etiology of ulcer. -Stress ulcer prophylaxis in select critically ill patients: Oral or via NG tube: 40 mg once daily or 40 mg initially, then another 40 mg dose given 6 to 8 hours later, followed by 40 mg once daily. Discontinue prophylaxis once critical illness and modifiable risk factors have resolved -Erosive esophagitis: Infants, Children, and Adolescents: Oral: 3 to <5 kg: 2.5 mg once daily. 5 kg to <10 kg: 5 mg once daily. 10 kg to <20 kg: 10 mg once daily. ≥20 kg: 20 mg once daily. Maintenance dose: Children and Adolescents: Oral: 5 kg to <10 kg: 5 mg once daily. 10 kg to <20 kg: 10 mg once daily. ≥20 kg: 20 mg once daily. Duration of therapy is dependent on age: Infant duration is up to 6 weeks and children and adolescent duration is 4 to 8 weeks.